Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00828763 · ClinicalTrials.gov registry record · Phase 1
GSK1349572 Mass Balance Study
A Phase 1 study, sponsored by GlaxoSmithKline.
- Completed
- Registry status
- Phase 1
- Development phase
- 6
- Enrollment target
NCT00828763 is a Phase 1 study that has completed, run by GlaxoSmithKline. The registered enrollment target is 6 participants.
The verdict
NCT00828763, a Phase 1 study, has completed, sponsored by GlaxoSmithKline.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 6 participants
- Enrollment target
Study Summary
Mass balance study to determine the recovery of a single radiolabelled dose of GSK1349572 from urine and feces
Interventions
- DRUG [14c}-GSK1349572
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2009-02 |
| Est. Completion | 2009-03 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00828763
The ClinicalTrials.gov registry entry for NCT00828763 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is GlaxoSmithKline, which has 1,345 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which [14c}-GSK1349572 is the first listed.
NCT00828763 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00828763 about?
NCT00828763 is a clinical study titled "GSK1349572 Mass Balance Study". Mass balance study to determine the recovery of a single radiolabelled dose of GSK1349572 from urine and feces
What is the current status of trial NCT00828763?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 6 participants. The study started on 2009-02. Estimated completion is 2009-03.
What interventions are being tested in trial NCT00828763?
The interventions under investigation include: [14c}-GSK1349572 (DRUG).
Who is sponsoring clinical trial NCT00828763?
This trial is sponsored by GlaxoSmithKline, which has 1,345 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.